JTCS Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Anoop K. Ganjoo
W. Dudley Johnson
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ganjoo, A. K.
Right arrow Articles by Johnson, W. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ganjoo, A. K.
Right arrow Articles by Johnson, W. D.

J Thorac Cardiovasc Surg 1996;112:208
© 1996 Mosby, Inc.


LETTERS TO THE EDITOR

Cardioprotective effects of ischemic preconditioning

Anoop K. Ganjoo, MCh, DNB, W. Dudley Johnson, MD

Milwaukee Heart Surgery Associates, S.C.
3300 S. 16th St.
Milwaukee, WI 53215

To the Editor:

We read with interest the article by Abd-Elfattah and Wechsler in the August issue of the Journal.Go 1 They cite their experimental data to explain the validity of the intermittent aortic crossclamp technique as a means of myocardial preservation, and they suggest that multiple brief crossclampings interspersed with periods of resumption of coronary blood flow tend to protect against subsequent ventricular dysfunction. We wish here to share our clinical observations in this regard.

In our practice of coronary artery bypass grafting of about 30 years, we have been using exclusively the method of intermittent ischemic fibrillatory arrest for up to 30 minutes, followed by unclamping of the aorta and additional perfusion of pump blood through the completed or partially completed distal vein graft anastomosis for 5 minutes. Inasmuch as a substantial proportion of our patients have diffuse coronary artery disease, and several of them require extensive endarterectomies, our total aortic crossclamp times for distal anastomoses vary greatly. In an analysis of our data some years back, we found that patients having a longer than usual total crossclamp time for the very first graft were more likely to die as a result of the operation. We also noted that patients who had shorter crossclamp times in the beginning of the operation, rather than later, did better (in terms of ease of separation from bypass, need for inotropic agents and intraaortic balloon pump support, intensive care unit stay, and operative mortality) than those patients who had longer clamp times at the start. Even though we were not then aware of the postischemic protective effects of preconditioning, it appears now that by doing grafts with shorter ischemic times first, we had been inadvertently practising ischemic preconditioning in patients in the better outcome group.

Most available literature (albeit mainly from animal laboratories) on ischemic preconditioning of the myocardium suggests that the beneficial effects of this phenomenon are best observed when the initial aortic crossclamp period is brief.Go Go 2-4 However, owing to the diffuse nature of coronary disease in our patients, it is sometimes not possible to do any graft in a relatively short time. To address this, we now make conscious efforts to precondition the heart before bypass grafting is begun. Soon after the start of bypass, the aorta is clamped and fibrillation is induced for 3 minutes. The clamp is then released and the heart allowed to beat for 5 minutes. This process is repeated once more, and the actual operation then proceeds in the usual fashion. This deliberate attempt at preconditioning seems innocuous and does not add significantly to the overall ischemic time. We are still in the midst of studying these patients, but our preliminary results appear promising so far. We will have to wait for more clinical evidence of advantages of ischemic preconditioning to appear, but it seems likely that it will be used more frequently in the practice of bypass grafting in the future.

[A reply was requested from Dr. Wechsler, and he declined to respond.]

References

  1. Abd-Elfattah AS, Wechsler AS. Intermittent aortic crossclamping prevents cumulative adenosine triphospate depletion, ventricular fibrillation, and dysfunction (stunning): Is it preconditioning? J THORAC CARDIOVASC SURG 1995;110:328-39.[Abstract/Free Full Text]
  2. Kloner RA, Yellon D. Does ischemic preconditioning occur in patients? J Am Coll Cardiol 1994;24:1133-42.[Abstract]
  3. Mehta JL, Yang B, Kerensky RA, Conti CR. Potential therapeutic implications of the phenomenon of ischemic preconditioning of the myocardium: lessons from the animal and catheterization laboratories. Am J Cardiol 1994;74:1270-1.[Medline]
  4. Ikonomidis JS, Weisel RD, Mickle DAG. Ischemic preconditioning: cardioprotection for cardiac surgery. J Card Surg 1994;9(Suppl):526-31.[Medline]




This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Anoop K. Ganjoo
W. Dudley Johnson
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ganjoo, A. K.
Right arrow Articles by Johnson, W. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ganjoo, A. K.
Right arrow Articles by Johnson, W. D.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS